Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
MRKMerck & Co.
FinDog View：Neutral
| Metric | CRL | MRK |
|---|
| Close | 273.41 | 144.91 |
| Market Cap | $13.1B | $358B |
| 1M | −4.62% | +6.57% |
| P/E (TTM) | — | 112.2 |
| Forward P/E | 24.2 | 19.5 |
| P/E 5-Yr Percentile | — | 81 |
| P/S | 3.3 | 5.4 |
| P/B | 4.6 | 8.5 |
| Dividend Yield | — | 2.87% |
| Latest Quarter Revenue | $1.0B | $16.6B |
| Revenue YoY | −2.7% | +5.1% |
| Gross Margin | — | 73.5% |
| Latest Quarter EPS | -0.03 | -0.54 |
| Avg Post-Earnings Move | ±1.8% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 3.50% |
| 90-Day Net Insider Buying | −$42.6M | −$30.0M |
CRL · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
